Caricamento...
HGG-26. DRAMATIC RESPONSE IN A CHILD TREATED FOR GLIOBLASTOMA WITH IMMUNE CHECK POINT INHIBITOR NIVOLUMAB
INTRODUCTION: Glioblastoma is not curable with current available therapies. Evidence has shown that tumours with a high mutational load can respond to immune check point inhibitors. PATIENT AND METHODS: We present the case of an 11 year old boy treated for intracranial malignant nerve sheet tumour a...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012745/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.298 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|